Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106.
about
Positron emission tomography imaging in multiple sclerosis-current status and future applicationsImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesTowards molecular imaging of multiple sclerosis.Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.PET imaging of stroke-induced neuroinflammation in mice using [18F]PBR06Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.Current imaging strategies in rheumatoid arthritisDecreased microglial activation in MS patients treated with glatiramer acetate.Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptorsIn vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.Influence of TSPO genotype on 11C-PBR28 standardized uptake values.Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.Imaging of microglia in patients with neurodegenerative disorders.Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.Sifting through the surfeit of neuroinflammation tracers.In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.Visual evaluation of kinetic characteristics of PET probe for neuroreceptors using a two-phase graphic plot analysis.Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
P2860
Q22242393-C641611C-B9CC-4CFB-8785-606EAD443BD7Q24642726-D1C12039-C999-4187-8E49-6D354CDD88B4Q33787779-68D47E84-6724-4594-93DB-9B99CCEBFC0DQ33905597-24F5151D-C8AD-471C-B0F7-65C71CE83DB2Q33925457-1F03E1F3-13FB-469D-A724-D2E56CD57BEFQ34076710-59B05EC7-FECE-42D3-A337-49D9CB93C081Q34680956-F3FEA343-DA12-4D47-961F-0FAD13AD52DFQ36094332-5298D6EE-8F1B-47FD-8E8B-5C3BF2E37460Q36337258-B831906D-B449-43B2-94C1-A5DC5364432DQ36338408-40ABC7E4-5C43-4924-997B-8C4CD3C205DAQ36492494-D71DA321-257F-455E-A611-2FFCA12EEF38Q36509182-FC6C726C-FDFF-4677-ACB4-D6E98D743ED9Q36953874-3CCDBBE8-CCAE-43F5-B0B4-AA40B3685DEDQ37087243-C512FB78-446C-4F53-AC62-49ACC88F02C4Q37449735-17109288-E5F6-46B4-B1F6-5D143EACB97DQ37718960-1B5EF5A0-8C14-4294-AB73-6B56DC514CE2Q38015834-D0CC6B24-AA08-4D2B-A458-42D9D99A35FAQ38667698-08435A20-591E-4881-9945-B753FFB7A174Q39666235-D3137FB6-D27C-4230-B338-9264862300ADQ40965410-28585562-B06D-4468-8505-FF7048820573Q43115816-5CDD0622-1E4B-41E5-8972-F8C75525C84EQ47277552-6700A152-0C72-486D-A0F9-FFC4511C5BE9Q48151150-3929B17C-75AD-41E3-8B82-5607EBD1219BQ48316857-A06728FC-FBCB-462A-9BA0-3F63FA3CEEC1Q51918361-3655374E-CF36-4327-B12A-C4231141785E
P2860
Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Quantitative analysis for esti ...... benzodiazepine receptor with [
@nl
Quantitative analysis for esti ...... receptor with [(11)C]DAA1106.
@en
type
label
Quantitative analysis for esti ...... benzodiazepine receptor with [
@nl
Quantitative analysis for esti ...... receptor with [(11)C]DAA1106.
@en
prefLabel
Quantitative analysis for esti ...... benzodiazepine receptor with [
@nl
Quantitative analysis for esti ...... receptor with [(11)C]DAA1106.
@en
P2093
P2860
P356
P1476
Quantitative analysis for esti ...... receptor with [(11)C]DAA1106.
@en
P2093
Akihiro Takano
Fumihiko Yasuno
Hinako Toyama
Hiroshi Ito
Kazutoshi Suzuki
Ming-Rong Zhang
Ryuji Nakao
Tetsuya Suhara
P2860
P304
P356
10.1038/SJ.JCBFM.9600325
P577
2006-05-10T00:00:00Z